参加暴露前预防的男男性行为者HIV自我检测试剂使用现状及影响因素分析

来源 :中华流行病学杂志 | 被引量 : 0次 | 上传用户:saarelff
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的:分析参加暴露前预防(PrEP)MSM的HIV自我检测(自检)试剂使用现状及相关影响因素。方法:2018年12月至2019年12月,使用“金数据”平台(www.jinshuju.com)对沈阳市、北京市、重庆市和深圳市参与多中心PrEP研究的MSM进行现况调查。结果:共有1 222例MSM研究对象,年龄(31.5±8.7)岁,最近3个月性伴数为3(n Pn 25,n Pn 75:2,6)个,与固定性伴、偶然性伴和商业性伴发生肛交时未使用安全套的比例分别为62.7%(456/727)、56.3%(440/781)和41.0%(16/39)。曾使用过HIV自检试剂的比例为74.5%(910/1 222),最近1年HIV自检次数为3(n Pn 25,n Pn 75:2,5)次。多因素logistic回归分析结果显示,HIV自检行为的相关影响因素中,分别相比于>40岁组、初中及以下文化程度、心理认同性别为女性、PrEP服药方式为事件驱动服药组、最近3个月未使用过新型毒品,18~岁组(an OR=2.06,95%n CI:1.35~3.14)、26~岁组(an OR=2.72,95%n CI:1.77~4.17)和31~岁组(an OR=1.76,95%n CI:1.19~2.59)、文化程度大学本科/大专(an OR=2.18,95%n CI:1.35~3.49)和研究生及以上(an OR=3.06,95%n CI:1.69~5.54)、心理认同性别为男性(an OR=3.22,95%n CI:1.55~6.70)、PrEP服药方式为每日服药组(an OR=1.35,95%n CI:1.03~1.78)、最近3个月使用过新型毒品(an OR=1.72,95%n CI:1.30~2.28)的HIV自检行为的比例更高。n 结论:MSM参与PrEP者HIV自检行为的比例较高,但高年龄组、PrEP服药方式为事件驱动服药及未使用过新型毒品的MSM对HIV自检行为比例较低。为评估PrEP使用效果及依从性,需为HIV自检比例较低的MSM提供更完善的自检服务。“,”Objective:To understand the current status of HIV self-testing reagent use in pre-exposure prophylaxis (PrEP) and related factors in men who have sex with men (MSM).Methods:From December 2018 to December 2019, “Gold data” online platform (www.jinshuju.com) was used to conduct multicenter PrEP studies in Shenyang, Beijing, Chongqing and Shenzhen of China.Results:A total of 1 222 MSM PrEP users were included in the multicenter study. The average age of the participants was (31.5±8.7) years, and the number of sexual partners in the past three months was 3 (n Pn 25,n Pn 75:2,6). The proportions of those who did not use condoms in anal sex with fixed, casual and commercial partners were 62.7% (456/727), 56.3% (440/781) and 41.0% (16/39), respectively. Up to 74.5% (910/1 222) of participants had used HIV self-testing reagents, and the number of HIV self-testing during last year was 3 (n Pn 25,n Pn 75:2,5). The multivariate logistic regression analysis indicated that compared with age group >40 years, those with education level of junior high school or below, those with psychological identity as female, event driven PrEP users, those never using new type drugs in past 3 months, the participants aged 18- years (a n OR=2.06, 95%n CI: 1.35-3.14), 26- years (an OR=2.72, 95%n CI: 1.77-4.17), 31- years (an OR=1.76, 95%n CI: 1.19-2.59), undergraduates (an OR=2.18, 95%n CI: 1.35-3.49), graduate students and above (an OR=3.06, 95%n CI: 1.69-5.54), those with psychological identity as male (an OR=3.22, 95%n CI: 1.55-6.70), daily PrEP users (an OR=1.35, 95%n CI: 1.03-1.78), and new type drug users in the past three months (an OR=1.72, 95%n CI: 1.30-2.28) had higher proportions of HIV self-testing behaviors.n Conclusions:The proportion of HIV self-testing in MSM PrEP users was high, while it was relatively low in older age group, event driven PrEP users and MSM never using new type drugs. To assess and improve the effectiveness and compliance of PrEPs, it is necessary to provide better HIV self-testing service for MSM with low HIV self-testing rate.
其他文献
本文介绍一例患者以无症状脾脏增大为首发表现,近期发现白细胞增高,具有慢性粒细胞白血病的典型骨髓象和细胞遗传学改变;以胸痛、咳嗽症状就诊,检查发现大量血性胸腔积液,胸水常
会议
Background::Estrogen is involved in the pathophysiological process of benign prostatic hyperplasia (BPH), in which epithelial-mesenchymal transition (EMT) plays
走进只有20平方米的黄斗书屋,那充满着温馨而又散发着徽墨幽香的书屋内,木制的玻璃门书橱及书架整整占据了三面墙,那一溜溜一排排的书籍齐刷刷地排列在 Into the only 20 s
本文介绍一例患者,女性,20岁。因发热一周于2007年12月入院。查体:重度贫血貌,全身皮肤、黏膜未见出血点,浅表淋巴结未触及肿大;胸骨压痛阳性,腹平软,肝脾肋下未触及。血常规
会议
目的:寻找一种短期内即能起效的止血药,降低危重出血的死亡率。方法:对5例各种原因引起的危重出血患者的临床资料进行回顾性分析。结果:应用重组活性Ⅶ因子可以在数小时甚至
会议
本文介绍一例患者淋巴结活检免疫组化染色CD21、CD23、CD35、EMA阳性,CD1α、CD79α、CD30、CD20均阴性。符合FDCS的特征性变化。目前FDCS的治疗方案仍有争议,手术、放疗和化疗
会议
从细胞水平和动物模型两个层次上研究了负载紫杉醇的聚乳酸纤维毡诱导U14宫颈癌细胞凋亡和抑制小鼠U14皮下移植瘤生长的能力.将U14细胞在纤维毡存在下孵育48 h,经Annexin V-F
本文介绍一例青年男性,持续发热,全血细胞减少,影像学(包括CT和PET-CT)均提示患者有左上肺实变+多发纵隔淋巴结肿大,且SUV值均>3,以及泼尼松治疗有效等等,这些都让人们认为淋巴瘤是
本文介绍一青年男性,病情危重,以纵隔大肿块为突出表现,伴多部位淋巴结肿大,骨质破坏,外周血嗜酸细胞明显增高,病例诊断疑难,少见疾病,治疗反应差,预后不好。入院后即按特发嗜酸细胞增
会议